Skip to main content
SpringerLink
Log in

Managing Incidental Findings

  • Chapter
  • First Online:
Lung Cancer Screening

  • 135 Accesses

Abstract

Lung cancer screening (LCS) with low-dose computed tomography is proven to reduce the risk of lung cancer mortality and all-cause mortality in high-risk individuals. Incidental findings (IF) reported on LDCT scans provide an opportunity for early intervention and management of undiagnosed or unrecognized disease processes. Within the lung cancer screening field, there is a lack of standardization for reporting on IFs and recommended diagnostic workups. In this chapter, we aim to discuss potential clinically significant incidental findings on LDCT, describe the reporting of IFs, review the common IFs in LCS, and discuss recommendations for management of IFs within a centralized LCS program.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society. American cancer society: cancer facts and figures 2021. Atlanta, GA: American Cancer Society; 2021.

    Google Scholar 

  2. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

    Article  PubMed Central  Google Scholar 

  3. Krist AH, US Preventive Services Task Force. Screening for lung cancer US preventive services task force recommendation statement. JAMA. 2021;325(10):962–70.

    Article  PubMed  Google Scholar 

  4. Mazzone PJ, Silvestri GA, Souter LH, Katki HA, Wiener RS, Detterbeck FC. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2013;160(5):E427–94.

    Article  Google Scholar 

  5. Tsai EB, Chiles C, Carter BW, Godoy MCB, Shroff GS, Munden RF, et al. Incidental findings on lung cancer screening: significance and management. Semin Ultrasound CT MR. 2018;39(3):273–81; https://www.sciencedirect.com/science/article/pii/S0887217118300209.

    Article  PubMed  Google Scholar 

  6. O’Sullivan JW, Muntinga T, Grigg S, JPA I. Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ. 2018;361:k2387; [cited 2021 Feb 23]. https://pubmed.ncbi.nlm.nih.gov/29914908/.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Powell DK. Patient explanation guidelines for incidentalomas: helping patients not to fear the delayed surveillance. AJR Am J Roentgenol. 2014;202:W602. https://doi.org/10.2214/AJR.13.12337.

    Article  PubMed  Google Scholar 

  8. American College of Radiology. ACR lung cancer screening CT incidental findings quick reference guide; 2021. https://www.acr.org/-/media/ACR/Files/Lung-Cancer-Screening-Resources/LCS-Incidental-Findings-Quick-Guide-Oct-2021.pdf.

    Google Scholar 

  9. Morgan L, Choi H, Reid M, Khawaja A, Mazzone PJ. Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening. Ann Am Thorac Soc. 2017;14(9):1450–6.

    Article  PubMed  Google Scholar 

  10. U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

    Google Scholar 

  11. Nguyen XV, Davies L, Eastwood JD, Hoang JK. Extrapulmonary findings and malignancies in participants screened with chest CT in the national lung screening trial. J Am Coll Radiol. 2017;14(3):324–30.

    Article  PubMed  Google Scholar 

  12. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, Brink JA, Baker ME, Federle MP, Foley WD, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010;7:754–73.

    Article  PubMed  Google Scholar 

  13. Berland LL. Overview of white papers of the ACR incidental findings committee II on adnexal, vascular, splenic, nodal, gallbladder, and biliary findings. J Am Coll Radiol. 2013;10:672–4.

    Article  PubMed  Google Scholar 

  14. Hoang JK, Langer JE, Middleton WD, Wu CC, Hammers LW, Cronan JJ, Tessler FN, Grant EG, Berland LL. Managing incidental thyroid nodules detected on imaging: white paper of the ACR incidental thyroid findings committee. J Am Coll Radiol. 2015;12:143–50.

    Article  PubMed  Google Scholar 

  15. Megibow AJ, Baker ME, Morgan DE, et al. Management of the incidental pancreatic cysts: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2017;14:911–23.

    Article  PubMed  Google Scholar 

  16. Mayo-Smith WW, Song JH, Boland GL, et al. Management of incidental adrenal masses: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2017;14:1038–44.

    Article  PubMed  Google Scholar 

  17. Gore RM, Pickhardt PJ, Mortele KJ, et al. J management of incidental liver lesions on CT: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2017;13:1429–37.

    Article  Google Scholar 

  18. Herts BR, Silverman SG, Hindman NM, et al. Management of the incidental renal mass on CT: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2018;15:264–73.

    Article  PubMed  Google Scholar 

  19. Munden RF, Carter BW, Chiles C, et al. Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A white paper of the ACR incidental findings committee. J Am Coll Radiol. 2018;15:1087–96.

    Article  PubMed  Google Scholar 

  20. Munden RF, Black WC, Hartman TE, et al. Managing incidental findings on thoracic CT: lung findings. A white paper of the ACR incidental findings committee. J Am Coll Radiol. 2021;18(9):1267–79.

    Article  PubMed  Google Scholar 

  21. Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, et al. Follow-up of incidental pulmonary nodules and the radiology report. J Am Coll Radiol. 2016;13(2 Suppl):R18–24.

    Article  PubMed  Google Scholar 

  22. American College of Radiology. Lung CT screening reporting and data system. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads.

  23. McKee BJ. In: Muller NL, Finlay G, editors. Lung-RADS standardized reporting for low-dose computed tomography for lung cancer screening; 2022; https://www.uptodate.com/contents/lung-rads-standardized-reporting-for-low-dose-computed-tomography-for-lung-cancer-screening#H687802840.

    Google Scholar 

  24. Kinsinger LS, Anderson C, Kim J, et al. Implementation of lung cancer screening in the veterans health administration. JAMA Intern Med. 2017;177(3):399–406.

    Article  PubMed  Google Scholar 

  25. Janssen K, Schertz K, Rubin N, Begnaud A. Incidental findings in a decentralized lung cancer screening program. Ann Am Thorac Soc. 2019;16(9):1198–200.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Reiter MJ, Nemesure A, Madu E, et al. Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in lung cnacer screening program. Lung Cancer. 2018;120:1–6.

    Article  PubMed  Google Scholar 

  27. Chung JH, Richards JC, Koelsch TL, et al. Screening for lung cancer: incidental pulmonary parenchymal findings. AJR. 2018;210:1–11.

    Article  Google Scholar 

  28. Steiger D, Siddiqi MF, Yip R, et al. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD. Clin Imaging. 2021;78:136–41.

    Article  PubMed  Google Scholar 

  29. Sverzellati N, Guerci L, Randi G, et al. Interstitial lung disease in a lung cancer screening trial. Eur Respir J. 2011;38:392–400.

    Article  CAS  PubMed  Google Scholar 

  30. Gy J, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology. 2013;268:563–71.

    Article  Google Scholar 

  31. Salvatore M, Henschke CI, Yip R, et al. Evidence of interstitial lung disease on low-dose chest CT images: prevalence, patterns, and progression. AJR. 2016;206:487–94.

    Article  PubMed  Google Scholar 

  32. Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, et al. Detection and early referral of patients with interstitial lung abnormalities an expert survey initiative. Chest. 2022;161(2):470–282.

    Article  PubMed  Google Scholar 

  33. Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Shemesh J, Henschke CI, Shaham D, et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology. 2010;257:541–8.

    Article  PubMed  Google Scholar 

  35. Malcolm KB, Dinwoodey DL, Cundiff MC, Regis SM, Borondy Kitts AK, Wald C, Lynch ML, Al-Husami W, McKee AB, McKee BJ. Qualitative coronary artery calcium assessment on CT lung screening exam helps predict first cardiac events. J Thorac Dis. 2018;10(5):2740–51. https://doi.org/10.21037/jtd.2018.04.76.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Mori H, Torii S, Kutyna M, et al. Coronary artery calcification and its progression: what does it really mean? J Am Coll Cardiol Img. 2018;11(1):127–42.

    Article  Google Scholar 

  37. Schulman-Marcus J, Valenti V, et al. Prognostic utility of coronary artery calcium scoring in active smokers: a 15-year follow-up study. Int J Cardiol. 2014;177(2):581–3.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Chiles C, Duan F, Gladish GW, et al. Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods. Radiology. 2015;276(1):82–90.

    Article  PubMed  Google Scholar 

  39. Rampinelli C, Preda L, Maniglio M, et al. Extrapulmonary malignancies detected at lung cancer screening. Radiology. 2011;261:293–9.

    Article  PubMed  Google Scholar 

  40. Bolland MJ, Grey AB, Gamble GD, Reid IR. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab. 2010;95:1174–81.

    Article  CAS  PubMed  Google Scholar 

  41. Romme EAPM, Murchison JT, Phang KF, Jansen FH, Rutten EPA, Wouters EFM, et al. Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD. J Bone Miner Res. 2012;27:2338–43.

    Article  PubMed  Google Scholar 

  42. Woo EK, Mansoubi H, Alyas F. Incidental vertebral fractures on multidetector CT images of the chest: prevalence and recognition. Clin Radiol. 2008;63(2):160–4.

    Article  CAS  PubMed  Google Scholar 

  43. Chan PL, Reddy T, Milne D, Bolland MJ. Incidental vertebral fractures on computed tomography. N Z Med J. 2012;125:45–50.

    PubMed  Google Scholar 

  44. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;140:e596–646.

    PubMed  PubMed Central  Google Scholar 

  45. Majeed A, Ruane B, Shusted CS, Austin M, Mirzozoda K, Pimpinelli M, Vojnika J, Ward L, Sundaram B, Lakhani P, Kane G, Lev Y, Barta JA. Frequency of statin prescription among individuals with coronary artery calcifications detected through lung cancer screening. Am J Med Qual. 2022;37(5):388–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, USA

    Brooke Ruane

  2. Department of Radiology, National Jewish Health, University of Colorado Denver, Denver, CO, USA

    Debra Dyer

Authors
  1. Brooke Ruane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debra Dyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brooke Ruane .

Editor information

Editors and Affiliations

  1. Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

    Gregory C. Kane

  2. Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

    Julie A. Barta

  3. Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA

    Ronald E. Myers

  4. Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA

    Nathaniel R. Evans III

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ruane, B., Dyer, D. (2023). Managing Incidental Findings. In: Kane, G.C., Barta, J.A., Myers, R.E., Evans III, N.R. (eds) Lung Cancer Screening . Springer, Cham. https://doi.org/10.1007/978-3-031-33596-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-33596-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-33595-2

  • Online ISBN: 978-3-031-33596-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation